The U.S. Food and Drug Administration (FDA) awarded a $120,950.00 firm fixed-price purchase order contract to Tissuse GMBH, a for-profit organization based in Germany. The contract is for the development of a multi-organ human-on-a-chip system, with a period of performance ending on December 31, 2024. The contract does not have a set-aside designation. Based on the FDA's role in evaluating medical technologies, this contract is likely related to the agency's efforts to advance the development of...
This is a federal contract award from the Food and Drug Administration (FDA) to the Health and Environmental Sciences Institute (HESI), a non-profit organization. The contract, worth $267,658.00, is for a project titled "VALIDATING HUMAN STEM CELL CARDIOMYOCYTE TECHNOLOGY FOR BETTER PREDICTIVE ASSESSMENT OF DRUG-INDUCED CARDIAC TOXICITY." The contract is a definitive contract with a firm fixed price. This contract appears to be supporting the FDA's efforts to evaluate the reliability...
The Department of Health and Human Services Food and Drug Administration awarded a $130,000 firm-fixed price purchase order to Dassault Systemes Americas Corp. to fulfill requirements for the agency's Critical Path computational whole heart modeling project. As requested in the original solicitation, Dassault Systemes will provide a one-year service agreement with an option for an additional year to perform whole human heart computations with a virtually implanted generic medical device using...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to TSE Systems, Inc., a for-profit manufacturer of biopotential and physiological monitoring equipment, for the delivery of implantable telemetry transmitters. The $127,350.00 contract does not have a set-aside designation and does not identify any subcontractors. The systems and services provided under this award directly support planned research studies related to areas like sleep...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Emulate Inc., a for-profit small business. The contract, valued at $145,260.00, is for the delivery of Emulate's CHIP-S1 Stretchable Chip, a product in their organ-on-a-chip technology line. This technology supports various FDA and HHS initiatives in areas such as personalized medicine, biosurveillance, infectious disease...
This $164,555.50 firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian government agency, to Emulate Inc., a small business contractor, for the procurement of two Zoe Culture Modules and two Orb Hub Modules of the Human Emulation System. The award, made under a small business set-aside, supports the FDA's regulatory science initiatives and efforts to advance non-animal testing approaches. Emulate Inc. has a long history of providing...
The Department of Health and Human Services Food and Drug Administration awarded a $727,122.40 firm fixed price purchase order to 3T Federal Solutions LLC of Austin, Texas. The contract calls for delivery of an automated high throughput patch clamp system to support the FDA's efforts to characterize drug effects on heart ion channels. The system must meet technical performance requirements to electrophysiologically assess individual cells at high volume, as requested in the small business...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Vitrocell Systems GMBH, a foreign-owned, for-profit limited liability company that manufactures specialized laboratory equipment. The $632,191.88 contract is for the provision of an e-cigarette smoking machine, electronic nicotine delivery systems (ENDS), and a 24/48 exposure module for 6.5mm cell culture inserts, along with post-warranty preventative maintenance...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $22,000 purchase order to Haemonetics Corporation for a TEG Manager software license. Haemonetics, doing business as Haemonetics, will deliver the licensed software as the prime contractor. The firm fixed price contract has a period of performance starting August 7, 2023 through August 31, 2024 in Boston, Massachusetts. No set aside designation or subcontractors were indicated. The HHS FDA regulates...
The Department of Health and Human Services' Food and Drug Administration awarded a purchase order to Ionoptix LLC, a for-profit organization, for the procurement of a Calcium and Contractility System plus four years of preventative maintenance. The potential value of the contract is $147,020.00 and it has a completion date of February 29, 2028. The contract is a firm fixed-price contract with no set-aside designation. The original solicitation was a pre-solicitation notice for a sole source...